yes i take peptides · shopping companion

Tesamorelin

Category · For EnergyStatus · FDACitations · 60WADA-banned

The verdict

FDA-approved for HIV-associated lipodystrophy. Two Phase 3 trials, several thousand patient-years. The most evidence-backed GHRH analog on the market — and priced accordingly.

By source — cost, legality, risk

Brand — Egrifta SV (Theratechnologies)
$2,400–$3,100/mo cash
FDA-approved Rx · HIV-associated lipodystrophy
Lowest. The trial drug; often covered by HIV-specific insurance pathways.
Compounded 503A pharmacy
$200–$500/mo
Rx · widely available off-label
Mid. The off-label visceral-fat path at hormone clinics (Marek, Hone, Defy).
RUO research peptide
$300–$450/mo
Sold 'for research only'
Highest. Unstable post-reconstitution; the bodybuilder fallback when clinic is too high.
Gray-market raw
$110–$120/mo
Unregulated overseas import
Same upstream molecule as RUO. Crypto/Wise pay; identity-uncertain vials priced below the per-mg floor are usually mis-labeled CJC-1295.

Sources · top 5 of 60

01— Tesamorelin. 2018. PMID: 31644039.
02Russo SC, et al. Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors. AIDS (London, England). 2024;38(12):1758-1764. PMID: 38905488.
03Grunfeld C, et al. Tesamorelin. Nature reviews. Drug discovery. 2011;10(2):95-6. PMID: 21283099.
04O'Neal R. Tesamorelin update. BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation. 2010;22(4):16-9. PMID: 21591600.
05Dhillon S. Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy. Drugs. 2011;71(8):1071-91. PMID: 21668043.